BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33138872)

  • 41. Ascertaining minimal clinically meaningful changes in symptoms of depression rated by the 15-item Centre for Epidemiologic Studies Depression Scale.
    Haase I; Winkeler M; Imgart H
    J Eval Clin Pract; 2022 Jun; 28(3):500-506. PubMed ID: 34647399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Making Sense of Variations in Prevalence Estimates of Depression in Cancer: A Co-Calibration of Commonly Used Depression Scales Using Rasch Analysis.
    Lambert SD; Clover K; Pallant JF; Britton B; King MT; Mitchell AJ; Carter G
    J Natl Compr Canc Netw; 2015 Oct; 13(10):1203-11. PubMed ID: 26483060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generalized anxiety disorder in older adults: examining the relation between clinician severity ratings and patient self-report measures.
    Hopko DR; Bourland SL; Stanley MA; Beck JG; Novy DM; Averill PM; Swann AC
    Depress Anxiety; 2000; 12(4):217-25. PubMed ID: 11195758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
    Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
    Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive behavioural therapy for tinnitus.
    Fuller T; Cima R; Langguth B; Mazurek B; Vlaeyen JW; Hoare DJ
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012614. PubMed ID: 31912887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.
    Thomas SA; Drummond AE; Lincoln NB; Palmer RL; das Nair R; Latimer NR; Hackney GL; Mandefield L; Walters SJ; Hatton RD; Cooper CL; Chater TF; England TJ; Callaghan P; Coates E; Sutherland KE; Eshtan SJ; Topcu G
    Health Technol Assess; 2019 Sep; 23(47):1-176. PubMed ID: 31524133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value added? A pragmatic analysis of the routine use of PHQ-9 and GAD-7 scales in primary care.
    Newman MW
    Gen Hosp Psychiatry; 2022; 79():15-18. PubMed ID: 36209615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care.
    Cameron IM; Crawford JR; Lawton K; Reid IC
    Br J Gen Pract; 2008 Jan; 58(546):32-6. PubMed ID: 18186994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing depression severity with a self-rated vs. rater-administered instrument in patients with epilepsy.
    Jamal-Omidi S; Collins C; Fulchiero E; Liu H; Colon-Zimmermann K; Fuentes-Casiano E; Tatsuoka C; Cassidy KA; Lhatoo S; Sajatovic M
    Epilepsy Behav; 2018 Aug; 85():52-57. PubMed ID: 29908384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A computerized version of the Patient Health Questionnaire-4 as an ultra-brief screening tool to detect emotional disorders in primary care.
    Cano-Vindel A; Muñoz-Navarro R; Medrano LA; Ruiz-Rodríguez P; González-Blanch C; Gómez-Castillo MD; Capafons A; Chacón F; Santolaya F;
    J Affect Disord; 2018 Jul; 234():247-255. PubMed ID: 29549826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe.
    Chibanda D; Verhey R; Gibson LJ; Munetsi E; Machando D; Rusakaniko S; Munjoma R; Araya R; Weiss HA; Abas M
    J Affect Disord; 2016 Jul; 198():50-5. PubMed ID: 27011359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9).
    Smarr KL; Keefer AL
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S454-66. PubMed ID: 22588766
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of depression and anxiety in empty nose syndrome after surgical treatment.
    Lee TJ; Fu CH; Wu CL; Tam YY; Huang CC; Chang PH; Chen YW; Wu MH
    Laryngoscope; 2016 Jun; 126(6):1284-9. PubMed ID: 26667794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
    Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
    Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring the relationship between generalised anxiety/depression scales and asthma-specific quality of life/control questionnaires in a specialist asthma clinic.
    Robinson R; Barber K; Jones G; Blakey J; Burhan H
    J Asthma; 2021 Jul; 58(7):912-920. PubMed ID: 32186425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a prognostic model for predicting depression severity in adult primary patients with depressive symptoms using the diamond longitudinal study.
    Chondros P; Davidson S; Wolfe R; Gilchrist G; Dowrick C; Griffiths F; Hegarty K; Herrman H; Gunn J
    J Affect Disord; 2018 Feb; 227():854-860. PubMed ID: 29689701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for major and minor depression in a multiethnic sample of Asian primary care patients: a comparison of the nine-item Patient Health Questionnaire (PHQ-9) and the 16-item Quick Inventory of Depressive Symptomatology - Self-Report (QIDS-SR16 ).
    Sung SC; Low CC; Fung DS; Chan YH
    Asia Pac Psychiatry; 2013 Dec; 5(4):249-58. PubMed ID: 24123813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The 12-Month Incidence and Predictors of PHQ-9-Screened Depressive Symptoms in Chinese Primary Care Patients.
    Chin WY; Wan EY; Choi EP; Chan KT; Lam CL
    Ann Fam Med; 2016; 14(1):47-53. PubMed ID: 26755783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.